8-K: Owlet to Exchange Warrants for 5.4M New Shares

Owlet, Inc. entered into an agreement to exchange Series A and Series B Warrants held by certain investors, including affiliates and management, for 5,426,429 newly issued shares of Class A Common Stock.

Summary

• Owlet, Inc. (the Company) entered into a privately negotiated Exchange Agreement on August 7, 2025, with certain holders of its Series A and Series B Warrants.
• The agreement involves the exchange of Series A Warrants relating to 7,215,737 shares and Series B Warrants relating to 1,799,021 shares.
• In return, the holders will receive an aggregate of 5,426,429 newly issued shares of the Company's Class A Common Stock.
• The valuation of the Warrants for the exchange was determined using a Black-Scholes option pricing model, based on the trailing 60-day volume-weighted average price of the Common Stock as of August 1, 2025, and its realized volatility.
• The transaction was approved by a special committee of the Company's board of directors, consisting solely of disinterested and independent directors.
• Consummation of the exchanges is subject to stockholder approval in accordance with Section 312.03 of the New York Stock Exchange Listed Company Manual and other customary closing conditions.
• If the closing does not occur by November 5, 2025, either the Company or a majority of the Holders may terminate the agreement.
• Holders of the exchanged shares have agreed to a 180-day lock-up period, restricting transfer or sale of the shares.
• The Company will file a shelf registration statement or prospectus supplement within 30 days after closing to register the resale of all exchanged shares.
• Key participants in the exchange include Eclipse Ventures LLC (affiliated with Chairman Lior Susan), Trilogy Equity Partners, LLC (affiliated with Board member Amy McCullough), Kurt Workman (CEO and Board member), and John Kim (Board member).

Sentiment

Score: 6

Explanation: The warrant exchange simplifies the capital structure by converting outstanding warrants into common stock, which can reduce future uncertainty. However, it involves significant dilution and notable related party transactions, which could be viewed cautiously by some investors.

Positives

• Simplifies the Company's capital structure by converting outstanding warrants into common stock, reducing future uncertainty related to warrant exercise.
• The transaction was approved by a special committee of independent directors, indicating a level of governance oversight for this related-party transaction.

Negatives

• The issuance of 5,426,429 new shares of Class A Common Stock will result in significant dilution for existing shareholders.
• A substantial portion of the newly issued shares will go to entities affiliated with or directly held by company management and board members, raising potential concerns about related party benefits.

Risks

• Inability to close the proposed exchanges due to the failure to obtain required stockholder approval for the Exchanged Shares Proposal.
• Failure to satisfy other customary closing conditions set forth in the Exchange Agreement.
• Potential negative market reaction to the dilution from the issuance of new shares or the optics of related party transactions.

Future Outlook

The Company expects to successfully close the warrant exchanges, subject to obtaining stockholder approval at its 2025 Annual Meeting and satisfying other customary closing conditions. Following the closing, the Company plans to file a shelf registration statement within 30 days to facilitate the resale of the newly issued shares.

Industry Context

This transaction represents a common strategy for companies to simplify their capital structure by converting outstanding warrants into common equity. Such moves can reduce the complexity of a company's balance sheet and eliminate potential future dilution events from warrant exercises, though they often result in immediate dilution. The involvement of related parties is not uncommon in smaller or emerging public companies, but it typically necessitates robust independent board oversight and shareholder approval to ensure fairness.

Comparison to Industry Standards

• The use of a Black-Scholes option pricing model for warrant valuation is a standard industry practice for financial reporting and transaction pricing.
• The requirement for stockholder approval for significant equity issuances, especially those involving related parties, aligns with NYSE listing standards (Section 312.03) and broader corporate governance best practices, similar to those observed in other publicly traded companies undertaking similar capital restructuring.

Corporate Governance

Related Party Transactions

• An entity affiliated with Eclipse Ventures LLC (whose sole managing member is Lior Susan, Chairman of the Board) will receive 3,898,906 shares of Common Stock in the Exchanges.
• Trilogy Equity Partners, LLC (whose President and Managing Director is Amy McCullough, a member of the Board) will receive 686,469 shares of Common Stock in the Exchanges.
• Kurt Workman, the Company's Chief Executive Officer and member of the Board, will receive 80,235 shares of Common Stock in the Exchanges.
• John Kim, a member of the Board, will receive 107,626 shares of Common Stock in the Exchanges.

Stakeholder Impact

• Shareholders: Will experience dilution from the issuance of 5,426,429 new shares, potentially impacting per-share metrics. The transaction aims to simplify the capital structure, which could be a long-term positive.
• Warrant Holders (participating): Will convert their warrants into common stock, gaining immediate equity ownership, subject to a 180-day lock-up period, and will have registration rights for future resale.
• Company: Simplifies its capital structure by eliminating outstanding warrants, potentially reducing future financial complexity and uncertainty.

Next Steps

• Include a proposal for stockholder approval of the Exchanged Shares in the proxy statement for the 2025 Annual Meeting.
• Obtain stockholder approval for the issuance of the Exchanged Shares at the 2025 Annual Meeting.
• Close the Exchanges, subject to stockholder approval and other customary closing conditions.
• File a shelf registration statement or prospectus supplement within thirty (30) days after the closing date of the Exchanges to register the resale of all Exchanged Shares.

Key Dates

Recommendation

The warrant exchange simplifies Owlet's capital structure by converting outstanding warrants into common stock, which can reduce future uncertainty regarding potential dilution. However, the issuance of over 5.4 million new shares represents significant dilution for existing shareholders, and the substantial involvement of related parties in the transaction warrants careful consideration. While the independent committee approval and stockholder vote requirement provide some governance oversight, the immediate dilution and the optics of related party benefits suggest a 'Hold' recommendation until the full impact on the company's valuation and future performance can be assessed post-transaction.

Keywords

Owlet, OWLT, warrant exchange, equity issuance, stock dilution, related party transaction, corporate governance, NYSE, Series A Warrants, Series B Warrants, Black-Scholes, SEC filing, 8-K